| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/FDHX-L92R-BATQ-2GE0 |
| P698 | PubMed publication ID | 11190811 |
| P2093 | author name string | Rebbeck TR | |
| Acs G | |||
| LiVolsi VA | |||
| Zhang PJ | |||
| Lawton TJ | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85-98 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications | |
| P478 | volume | 115 |
| Q58423595 | A Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast Disease |
| Q24815807 | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
| Q24806155 | Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator |
| Q42446155 | Aggressive giant fibroepithelial lesion with unusual vascular stroma--a case report |
| Q34132812 | Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study |
| Q89974098 | American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications |
| Q21195234 | An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ |
| Q53533827 | Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. |
| Q28203542 | Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study |
| Q57105168 | Breast Cancer Heterogeneity: A focus on Epigenetics and In Vitro 3D Model Systems |
| Q34158093 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression |
| Q33235269 | CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer |
| Q36741554 | CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer |
| Q35146526 | Cadherin-catenin complex dissociation in lobular neoplasia of the breast |
| Q33738278 | Clinicopathological study of male breast carcinoma: 24 years of experience |
| Q36924391 | Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions |
| Q50505471 | Connexins, E-cadherin, Claudin-7 and β-catenin transiently form junctional nexuses during the post-natal mammary gland development. |
| Q34883526 | Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells |
| Q37318608 | DNA copy number aberrations in breast cancer by array comparative genomic hybridization |
| Q34274795 | DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma |
| Q37740955 | Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. |
| Q30463534 | Ductal carcinoma in situ of the breast: a surgical perspective |
| Q35915812 | E-Cadherin as a diagnostic biomarker in breast cancer |
| Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
| Q92969736 | E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients |
| Q38673790 | EMT: Present and future in clinical oncology |
| Q37690220 | Evaluation of ultra-deep targeted sequencing for personalized breast cancer care |
| Q92307769 | Expression Analysis of the Mediators of Epithelial to Mesenchymal Transition and Early Risk Assessment of Therapeutic Failure in Laryngeal Carcinoma |
| Q33502878 | Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast |
| Q41847937 | Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study |
| Q37145151 | Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas |
| Q36695838 | Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1. |
| Q40638709 | Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium |
| Q37233231 | Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast |
| Q35142983 | In situ malignant transformation and progenitor-mediated cell budding: two different pathways for breast ductal and lobular tumor invasion |
| Q53040493 | Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. |
| Q37531363 | Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast |
| Q30446033 | Invasive ductolobular carcinoma of the breast: spectrum of mammographic, ultrasound and magnetic resonance imaging findings correlated with proportion of the lobular component |
| Q37586533 | Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor |
| Q33945022 | Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies |
| Q48118284 | Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases |
| Q45191001 | Invasive lobular carcinoma: to grade or not to grade |
| Q61970366 | Konzept und Problematik der lobulären Neoplasie |
| Q34179808 | Late age at first full term birth is strongly associated with lobular breast cancer |
| Q36449304 | Lobular Breast Cancer in a Male Patient with a Previous History of Irradiation Due to Hodgkin's Disease |
| Q37740943 | Lobular neoplasia: morphology, biological potential and management in core biopsies |
| Q80827541 | Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix |
| Q83694847 | Metastatic breast carcinoma simulating linitis plastica of the colon: report of a case |
| Q48221533 | Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology |
| Q41605699 | Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status |
| Q57713568 | P-Cadherin Expression in Canine Mammary Tissues |
| Q30725747 | Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment |
| Q35625957 | Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ |
| Q53316378 | Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix. |
| Q36728786 | Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome |
| Q28076697 | Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications |
| Q79103489 | Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65–79 years of age |
| Q37120162 | Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer |
| Q33903091 | Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population |
| Q83130027 | Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001 |
| Q36556184 | Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles |
| Q34023682 | Significance of immunohistochemistry in breast cancer |
| Q38406396 | Strong Correlation of Indoleamine 2,3-Dioxygenase 1 Expression with Basal-Like Phenotype and Increased Lymphocytic Infiltration in Triple-Negative Breast Cancer |
| Q90149927 | Survival skills ensure that cancer spreads |
| Q39630958 | The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis |
| Q79401511 | The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study |
| Q64979473 | The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast. |
| Q91559519 | The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts |
| Q34575496 | The myoepithelial cell layer may serve as a potential trigger factor for different outcomes of stage-matched invasive lobular and ductal breast cancers |
| Q37169805 | Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern |
Search more.